Market Research Logo

Agilent Technologies Inc (A) - Product Pipeline Analysis, 2017 Update


Agilent Technologies, Inc. (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company offers its products to diagnostics, life sciences and applied chemical markets. It serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Agilent Technologies Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Agilent Technologies Inc Company Overview
Agilent Technologies Inc Company Snapshot
Agilent Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Agilent Technologies Inc – Pipeline Analysis Overview
Business Description
Agilent Technologies Inc - Key Facts
Agilent Technologies Inc - Major Products and Services
Agilent Technologies Inc Pipeline Products by Development Stage
Agilent Technologies Inc Pipeline Products Overview
Amgen Companion Diagnostic Test - Gastroesophageal Cancer
Amgen Companion Diagnostic Test - Gastroesophageal Cancer Product Overview
Bioenergetic Health Index Test
Bioenergetic Health Index Test Product Overview
Companion Diagnostic PD-L1 Test
Companion Diagnostic PD-L1 Test Product Overview
GenetiSure Dx Postnatal Assay
GenetiSure Dx Postnatal Assay Product Overview
IQFISH Hybridization Based Companion Diagnostic Test
IQFISH Hybridization Based Companion Diagnostic Test Product Overview
MET4 pharmDx Companion Diagnostic Assay - Cancer
MET4 pharmDx Companion Diagnostic Assay - Cancer Product Overview
MK-0646 Companion Diagnostic Test
MK-0646 Companion Diagnostic Test Product Overview
MK-2206 Companion Diagnostic Test
MK-2206 Companion Diagnostic Test Product Overview
MK-3475 Companion Diagnostic Test
MK-3475 Companion Diagnostic Test Product Overview
MK-8669 Companion Diagnostic Test
MK-8669 Companion Diagnostic Test Product Overview
Agilent Technologies Inc - Key Competitors
Agilent Technologies Inc - Key Employees
Agilent Technologies Inc - Key Employee Biographies
Agilent Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Agilent Technologies Inc, Recent Developments
Mar 30, 2017: Agilent Technologies Showcases Cancer Research Innovations at AACR 2017
Mar 20, 2017: Agilent Technologies Hires Samraat Sam Raha to Head Strategy and Corporate Development
Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman
Mar 02, 2017: Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies
Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results
Jan 31, 2017: Hematogenix announces the recognition by Merck as one of the national reference laboratories offering PD-L1 testing for KEYTRUDA
Jan 31, 2017: Agilent Technologies Expands Dako's CE Marked PD-L1 IHC 22C3 pharmDx Companion Diagnostics
Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies
Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit
Dec 05, 2016: Cancer Genetics, Inc. Listed by Merck as a National Reference Laboratory for KEYTRUDA (pembrolizumab) Companion Diagnostic Testing
About GlobalData
Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report